Oxidative modification of proteins in pediatric cystic fibrosis with bacterial infections

Izabela Sadowska-Bartosz1, Sabina Galiniak1, Grzegorz Bartosz2

  • 1Department of Biochemistry and Cell Biology, University of Rzeszów, Zelwerowicza 4, 35-601 Rzeszów, Poland.

Insights

Cystic fibrosis (CF) patients with chronic lung infections show increased oxidative stress markers. Glycophores and protein carbonyls are useful indicators of oxidative damage in CF patients.

Area of Science:

  • Biochemistry
  • Pulmonology
  • Medical Research

Background:

  • Chronic lung infections by Pseudomonas aeruginosa and Staphylococcus aureus are common in cystic fibrosis (CF) patients.
  • These infections induce significant oxidative stress in CF patients.
  • Understanding oxidative stress markers is crucial for managing CF.

Purpose of the Study:

  • To compare markers of plasma protein oxidative damage and glycoxidation in CF patients with chronic P. aeruginosa and S. aureus infections.
  • To assess erythrocyte antioxidant enzyme activities in these patients.
  • To investigate nitric oxide concentration in exhaled air of CF patients.

Main Methods:

  • Comparison of plasma protein oxidative damage and glycoxidation markers (glycophores, carbonyl groups, kynurenine).
  • Measurement of erythrocyte glutathione S-transferase activity.
  • Quantification of nitric oxide in exhaled air.

Main Results:

  • Elevated glycophore and protein carbonyl levels were observed in CF patients infected with P. aeruginosa and S. aureus compared to controls.
  • Increased glutathione S-transferase activity was noted in both infection groups.
  • Kynurenine levels were elevated specifically in S. aureus infected CF patients.

Conclusions:

  • These findings confirm the presence of oxidative stress in CF patients with chronic lung infections.
  • Glycophores and protein carbonyls serve as valuable markers for oxidative modifications of plasma proteins in CF.
  • Further research into antioxidant strategies for CF management is warranted.

Related Concept Videos

Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
1.1K
Protein Modifications in the RER01:26

Protein Modifications in the RER

Modification of secretory and transmembrane proteins entering the rough ER begins in the ER lumen. These modifications aid in protein folding and stabilize the acquired tertiary structure. Protein modifications in the rough ER co-occur at different stages of protein folding.
Broadly, these modifications can be categorized into four main categories — glycosylation, formation of disulfide bonds, assembly of protein subunits, and specific proteolytic cleavages like removal of signal...
5.6K
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
657
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
8.2K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
5.0K
Bacterial Protein Maturation01:26

Bacterial Protein Maturation

Bacterial protein maturation is a tightly regulated process that ensures newly synthesized polypeptides achieve correct functional conformations. This maturation involves a series of modifications, folding events, and quality control steps, often assisted by specialized chaperone proteins.N-Terminal ModificationsThe maturation of bacterial polypeptides begins cotranslationally as the polypeptide exits the ribosome. The first amino acid, N-formylmethionine (fMet), is typically modified at the...
744